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Pedicled Omental Flaps 
Sir, 
I read with interest the article "Use of a Pedicled 
Omental Flap in the Treatment of an Infected Vascular 
Prosthetic Graft .1 The authors suggest that the 
presented case is to their knowledge the first report in 
literature. I am sorry to contradict them but my article 
describing a similar case was published 24 years ago 
in the journal Chirurgie. 2 1 am pleased to say that my 
patient remained free of recurrent infection with a 
patent graft during the 14 years following treatment 
by a pedicled omental flap. I have subsequently used 
this technique in four other cases with success in three 
and failure in one. 
G. Bonneton 
Grenoble, France 
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Arterial Graft Preservation 
Sir, 
I read with interest he paper by Vischjager et al. on 
arterial grafts preservation, 1 however I believe that 
some important information is lacking. 
The Authors correctly compare arterial with organ 
transplantation and state that the "gold standard" of 
organ preservation is presently cold storage in UW 
solution. This may be true for solid organs, but a wide 
body of literature demonstrates that long-term main- 
tenance of both morphological and physiological 
arterial characteristics is currently possible only with 
cryopreservation techniques, in the absence of data 
using other methods. 2 As stated by the authors, only 
short-term results of arterial preservation in UW 
solution are known; the results of a preservation 
interval of 14 days appear insufficient to draw 
conclusions on UW solution performance in creating a
bank of arteries. Moreover, functional response to 
contractile and relaxing agents showed a significant 
decrease over time, with a residual overall function of 
approximately 50% after 21 days and 0% after 60 
days. ~ These data argue against the possibility of 
extending UW solution preservation over 2 weeks. 
Since the Authors are currently studying the effects of 
longer storage intervals, it would have been more 
interesting to assess them all in a single paper, 
possibly with a comparison with cryopreserved 
specimens. 
The fate of morphologically preserved endothelial 
cells on the graft surface also remains obscure in the 
study. Although the morphological observations 
before and after arterial implantation suggest better 
preservation of endothelial cells in UW-preserved 
grafts, the actual behaviour of these cells under 
arterial flow conditions is not disclosed in the study. In 
fact, the Authors state that "... a neoendothelial layer 
had developed in the PBS groups (auto and allo 
PBS)...'. 1 Thus, the observation of good endothelial 
coverage in the implanted UW arteries is of little help 
in determining endothelial cell behaviour and viabil- 
ity. We have previously shown that morphologically 
intact, cryopreserved endothelial cells are not able to 
withstand arterial flow in the rabbit model, although 
complete re-endothelialisation occurs within few 
weeks. 3
Endothelial denudation occurs commonly even in 
freshly implanted human autologous veins, and the 
re-endothelialisation time is dependent on the amount 
of surgical damage. 4 It is known that endothelial 
coverage is easier in the animal model; therefore the 
data presented indicate only a different morphology 
of the endothelial layer in the treatment groups, and 
not necessarily the viability of the endothelial cells 
treated with UW solution. This issue is of paramount 
importance, since the benefit of preserving an intact 
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endothelial layer is controversial in allografts. 2 The 
endothelium provides antithrombotic haracteristics 
which may turn into pro-thrombotic stimuli under 
several circumstances and, most importantly, it con- 
stitutes a great antigenic hallenge to the host. 
G. Faggiol i  
Bologna, Italy 
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Cytokine Profiles in Abdominal Aortic Aneurysms 
Sir, 
Louwrens and colleagues 1 present an interesting 
paper highlighting the important role of the plasmino- 
gen activator system in the pathogenesis ofabdominal 
aortic aneurysms (AAAs). The study indicates how 
the expression of the various components of this 
system might be cytokine dependent, in particular IL- 
1~. However, it seems that they are not fully up to date 
with the literature on cytokines and aneurysmal 
pathology. IL-I~ is not the only cytokine which has 
been found to be elevated in AAA wall in comparison 
with normal control aortas. A recent study by New- 
man et al. 2 demonstrated that both IL-I~ and TNF-a 
were significantly increased in AAA compared to 
cadaveric ontrols. In addition a more detailed study 
of the cytokinetic profile of AAA 3 showed that IL-2, 
IL-2 receptor, IFN-7 and IL-4 were all elevated in the 
aneurysmal wall. These mediators were absent in the 
control samples of human aorta. The role of the 
immune system is a fundamental part of the pathoge- 
nesis of AAAs and requires further detailed studies. 
I. Masood 
Leicester, U.K. 
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Quality of Life After Treatment of Intermittent 
Claudication 
S~ 
We were interested to read the recent paper by Currie 
et al. 1 demonstrating the impact of treatment of 
intermittent claudication on quality of life. Angio- 
plasty and surgery offer short-term improvement to 
quality of life but the effect of restenosis and graft 
occlusion may minimise this improvement or in the 
latter significantly reduce quality of life. In such a non- 
randomised trial it is also not surprising that patients 
in the operative group have lower baseline quality of 
life. Supervised exercise programmes undoubtedly 
increase xercise tolerance in compliant patients 2 but 
the authors have not reported the compliance rate of 
patients in their unsupervised exercise group. Patients 
who poorly comply with exercise would be unlikely to 
report significant improvement in quality of life. We 
have shown that a daily home exercise programme, 
supervised weekly by a physiotherapist for the first 
month achieves good compliance, increased walking 
distances and improved quality of life as assessed by 
the Nottingham Health Profile questionnaire. 3 
We share the authors concerns that exercise, 
although improving local symptoms may have 
adverse remote consequences with neutrophil activa- 
tion 4 and systemic vascular endothelial damage, s This 
may influence atherogenesis and therefore be impli- 
cated in the excess cardiovascular mortality in these 
patients. Surgery attenuates but does not normalise 
the increase in vascular permeability after treadmill 
exercise. 6 Angioplasty itself is effected by cracking of 
the atherosclerotic plaque, exposing the subintimal 
layer. Perhaps angioplasty also has an adverse effect 
on future cardiovascular mortality? We suggest hat 
we should have more information on the effect of 
therapeutic intervention on putative biochemical 
markers of vascular inflammation, rather than assess- 
ing outcome simply on the basis of quality of life. 
P. V. Tisi and C. P. Shearman 
Southampton, U.K. 
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